Navigation Links
Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program
Date:12/15/2009

WALTHAM, Mass., Dec. 15 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) today announced that the Company has received $731,000 in research funding to support the ongoing development of new treatments for Friedreich's ataxia from the Muscular Dystrophy Association (MDA). This grant will support the completion of preclinical GLP toxicology testing and GMP manufacture of a drug candidate for human clinical trials. Support from the MDA not only provides important funding for Repligen's research but it also provides access to a global network of scientists, physicians and patients. This is the second research grant that Repligen has received from the MDA to support its Friedreich's ataxia program.

"We would like to thank the Muscular Dystrophy Association for their continued support of our Friedreich's ataxia program," stated Walter C. Herlihy, President and Chief Executive Officer of Repligen Corporation. "Funding from the MDA has allowed us to accelerate the development of a treatment that has the potential to be the first drug to modify the course of this very debilitating disease."

Friedreich's ataxia is an inherited neurodegenerative disease caused by a single gene defect that results in inadequate production of the protein frataxin. Low levels of frataxin lead to degeneration of both the nerves controlling muscle movements in the arms and legs and the nerve tissue in the spinal cord. Preclinical studies have shown that specific HDAC inhibitors increase production of the protein frataxin which may have the potential to arrest disease progression in patients with Friedreich's ataxia. A potential clinical candidate synthesized by Repligen is being characterized in preclinical models to fully assess its pharmacologic, toxicologic and pharmacodynamic profile.

About the Muscular Dystrophy A
'/>"/>

SOURCE Repligen Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Repligen Announces Conference Call of Third Quarter Fiscal Year 2008 Results
2. Repligen Announces Settlement with Bristol-Myers Squibb in Orencia(R) Lawsuit
3. Repligen Reports Fourth Quarter and Fiscal Year 2008 Financial Results
4. Repligen Announces Conference Call of First Quarter Fiscal Year 2009 Results
5. Repligen Receives Research Grants to Support Friedreichs Ataxia Development Program
6. Repligen Announces Publication of Positive Results with Proprietary HDAC Inhibitor in Huntingtons Disease Model
7. Repligen to Present at the 2008 UBS Global Life Sciences Conference Wednesday, September 24th, 1:00 p.m. EDT
8. Repligen to Present at the Rodman & Renshaw 10th Annual Healthcare Conference Monday, November 10th, 4:55 p.m. EST
9. Repligen Announces Conference Call of Third Quarter Fiscal Year 2009 Results
10. Repligen to Present at the BIO CEO & Investor Conference Monday, February 9th, 11:30 a.m. EST
11. Repligen Reports Third Quarter Fiscal Year 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... Automated cell culture systems are instruments that mechanically ... allow production of optimum cells at a large scale ... and industries and biopharmaceutical companies. Cell culture automation systems ... cell-based assays, and cellular expression systems as they save ... Global Cell Culture market will grow at ...
(Date:7/22/2014)...  Neogen Corporation (NASDAQ: NEOG ) announced ... ended May 31, increased 19% from the previous year ... to the prior year,s $27,190,000. Adjusted for a 3-for-2 ... in the current year were $0.76, compared to $0.75 ... the 2014 fiscal year established new all-time highs for ...
(Date:7/22/2014)... , July 22, 2014 Hussey ... of MD-Cu 29 antimicrobial copper announces Pullman Regional ... the first EPA-registered antimicrobial solid touch surface, at a ... 99.9% of MRSA, E-coli and other bacteria within 2 hours ... in protecting against bacteria and infectious diseases in its ...
(Date:7/22/2014)... July 22, 2014  United Therapeutics Corporation (NASDAQ: ... will release its second quarter 2014 financial results ... United Therapeutics will host a half-hour ... a.m. Eastern Time.  The teleconference is accessible by ... rebroadcast of the teleconference will be available for ...
Breaking Biology Technology:Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 2Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 3Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 4Neogen reports 19% increase in annual revenues 2Neogen reports 19% increase in annual revenues 3Neogen reports 19% increase in annual revenues 4Neogen reports 19% increase in annual revenues 5Neogen reports 19% increase in annual revenues 6Neogen reports 19% increase in annual revenues 7Neogen reports 19% increase in annual revenues 8Pullman Regional Hospital changes more than 1,100 touch points to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 2Pullman Regional Hospital changes more than 1,100 touch points to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 3
... In trying to explain the complexities of the biotech industry ... that it is a long, painstaking and expensive process. What they ... drug discovery and development process shows us the following pathway: ... , , If the patent life of a drug is ...
... Brian Howell, who elevated technology and business coverage at ... lung cancer. He was 53. , ,Before becoming ... was features editor and, previously, national-foreign editor of the ... included reporting and editing stints in Montana, Minnesota and ...
... lot of talk about customers. Calling on customers. Securing ... many years of loose talk about brand building that ... the brand reputation as much as the vendor does. ... two incredible software companies, customers never really went out ...
Cached Biology Technology:The Complexities, Cost of Midwest Biotech Drug Development 2The Complexities, Cost of Midwest Biotech Drug Development 3The Complexities, Cost of Midwest Biotech Drug Development 4Madison Magazine Editor Dies of Lung Cancer 2The Secret of Success: Listen To Customers 2The Secret of Success: Listen To Customers 3
(Date:7/21/2014)... conserve water and save on your utility bill? A ... in the current issue of the journal Environment ... Most Effective Actions U.S. Households Can Take to Curb ... substantially by simple actions such as installing more efficient ... the suggestions may be familiar, the researchers are the ...
(Date:7/21/2014)... 21, 2014 Dysfunction in dopamine signaling profoundly ... in the brain,s prefrontal cortex and may be ... such as schizophrenia, according to UC Irvine scientists. ... brain cells that receive this neurotransmitter showed for ... a variety of behavioral and physiological functions regulated ...
(Date:7/21/2014)... A team of University of California, Riverside Bourns College of ... the grates of a backyard grill reduces by 70 percent ... The one-eighth inch thick steel carbon plate with an insulated ... a slit into the grill to allow the plate to ... by grill manufacturers who could sell new grills with the ...
Breaking Biology News(10 mins):Researchers provide guide to household water conservation 2Researchers provide guide to household water conservation 3UCI researchers find epigenetic tie to neuropsychiatric disorders 2Catching grease to cut grill pollution 2
... Conn. Triceratops and Torosaurus have long been ... discovery traces the giants, family tree further back in time, ... before its more well-known descendants, making it the earliest known ... Titanoceratops after the Greek myth of the Titans, ...
... brightly glowing nanoparticles may soon be used to light ... U.S. Food and Drug Administration (FDA) has approved the first clinical ... time the FDA has approved using an inorganic material in the ... finally puts a federal approval stamp on all the assumptions we ...
... in genes requires cells to process "messenger RNA" molecules before ... It was long believed that this was simply part ... new types of protein but recent work has made it ... And so attention is gradually shifting to asking why ...
Cached Biology News:Newly discovered dinosaur likely father of Triceratops 2'Cornell Dots' that light up cancer cells go into clinical trials 2If junk DNA is useful, why is it not shared more equally? 2
... Physical form: Solution in 50% glycerol containing 20 mM ... and 20 mM NaCl Preparation Unit Definition: One unit ... equivalent to a ΔA 260 of 1.0 in ... volume 2.625 ml). Assay: SDS-PAGE ≥ 90 % ...
Mouse monoclonal antibody to PPP2R2C - protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), gamma isoform...
Mouse monoclonal antibody to PARK2 - Parkinson disease (autosomal recessive, juvenile) 2, parkin...
... quantitation kit is used to quantitate double-stranded DNA ... RNA or protein. With this kit, DNA is ... detected with a VersaFluor or other fluorometer. The ... ng per ml to 5 micrograms per ml ...
Biology Products: